Distribution of non-motor symptoms in idiopathic Parkinson's disease and secondary Parkinsonism
(2018) In Journal of Multidisciplinary Healthcare 11. p.525-534- Abstract
BACKGROUND: Non-motor symptoms (NMS) are frequent in patients with idiopathic Parkinson's disease (IPD). Clinical expressions, postulated pathophysiological mechanisms, and responsiveness to antiparkinson medication represent differences between IPD and secondary Parkinsonism (SP).
OBJECTIVE: To evaluate NMS expressions in IPD, SP, and a matched control group.
METHODS: The accepted criteria for IPD and SP were controlled for the participants who were consecutively recruited at two outdoor patient clinics. The Well-Being Map™ was used as the evaluation instrument. These were completed by the participants before their visit. The controls consisted of non-Parkinsonian individuals who were matched by age and... (More)
BACKGROUND: Non-motor symptoms (NMS) are frequent in patients with idiopathic Parkinson's disease (IPD). Clinical expressions, postulated pathophysiological mechanisms, and responsiveness to antiparkinson medication represent differences between IPD and secondary Parkinsonism (SP).
OBJECTIVE: To evaluate NMS expressions in IPD, SP, and a matched control group.
METHODS: The accepted criteria for IPD and SP were controlled for the participants who were consecutively recruited at two outdoor patient clinics. The Well-Being Map™ was used as the evaluation instrument. These were completed by the participants before their visit. The controls consisted of non-Parkinsonian individuals who were matched by age and gender.
RESULTS: A total of 185 participants participated in the study, IPD/SP/controls; n=73/53 and 59, respectively. The mean age was 74 years, and the median duration of disease was 6/3 years. Differences were shown between the combined IPD/SP groups and the controls. Limited differences between the IPD and SP groups could be demonstrated. Symptoms such as pain, decreased taste, as well as sleep and bladder disturbances were more frequent in the IPD group. When more than minor problems with moving were reported, disturbances in sleep and digestion were also noted to a large extent.
CONCLUSION: Despite differences in the pathophysiological mechanisms between IPD and SP, the study showed only minor differences in the expression of NMS. IPD and SP reported statistically more significant problems in all items compared to the controls. Sleeping problems were strongly associated with symptoms from the gastrointestinal tract, but sleep was only affected by longer disease duration to a minor extent. Motor symptoms, such as morning stiffness, were common in all three groups. Neurodegenerative diseases might have more complex expressions in common than what we have known before and it is certainly not a part of normal aging.
(Less)
- author
- Skogar, Orjan and Nilsson, Mats
- publishing date
- 2018
- type
- Contribution to journal
- publication status
- published
- in
- Journal of Multidisciplinary Healthcare
- volume
- 11
- pages
- 525 - 534
- publisher
- Dove Medical Press Ltd.
- external identifiers
-
- pmid:30323614
- scopus:85059011681
- ISSN
- 1178-2390
- DOI
- 10.2147/JMDH.S170307
- language
- English
- LU publication?
- no
- id
- 09776e6a-fc55-4983-860f-4601583a8556
- date added to LUP
- 2024-05-08 14:51:03
- date last changed
- 2024-05-09 04:00:59
@article{09776e6a-fc55-4983-860f-4601583a8556,
abstract = {{<p>BACKGROUND: Non-motor symptoms (NMS) are frequent in patients with idiopathic Parkinson's disease (IPD). Clinical expressions, postulated pathophysiological mechanisms, and responsiveness to antiparkinson medication represent differences between IPD and secondary Parkinsonism (SP).</p><p>OBJECTIVE: To evaluate NMS expressions in IPD, SP, and a matched control group.</p><p>METHODS: The accepted criteria for IPD and SP were controlled for the participants who were consecutively recruited at two outdoor patient clinics. The Well-Being Map™ was used as the evaluation instrument. These were completed by the participants before their visit. The controls consisted of non-Parkinsonian individuals who were matched by age and gender.</p><p>RESULTS: A total of 185 participants participated in the study, IPD/SP/controls; n=73/53 and 59, respectively. The mean age was 74 years, and the median duration of disease was 6/3 years. Differences were shown between the combined IPD/SP groups and the controls. Limited differences between the IPD and SP groups could be demonstrated. Symptoms such as pain, decreased taste, as well as sleep and bladder disturbances were more frequent in the IPD group. When more than minor problems with moving were reported, disturbances in sleep and digestion were also noted to a large extent.</p><p>CONCLUSION: Despite differences in the pathophysiological mechanisms between IPD and SP, the study showed only minor differences in the expression of NMS. IPD and SP reported statistically more significant problems in all items compared to the controls. Sleeping problems were strongly associated with symptoms from the gastrointestinal tract, but sleep was only affected by longer disease duration to a minor extent. Motor symptoms, such as morning stiffness, were common in all three groups. Neurodegenerative diseases might have more complex expressions in common than what we have known before and it is certainly not a part of normal aging.</p>}},
author = {{Skogar, Orjan and Nilsson, Mats}},
issn = {{1178-2390}},
language = {{eng}},
pages = {{525--534}},
publisher = {{Dove Medical Press Ltd.}},
series = {{Journal of Multidisciplinary Healthcare}},
title = {{Distribution of non-motor symptoms in idiopathic Parkinson's disease and secondary Parkinsonism}},
url = {{http://dx.doi.org/10.2147/JMDH.S170307}},
doi = {{10.2147/JMDH.S170307}},
volume = {{11}},
year = {{2018}},
}